Docket for 16-360
| No. 16-360 | |
| Title: |
| Mylan Pharmaceuticals Inc., et al., Petitioners |
| v. |
| Acorda Therapeutics Inc., et al. |
|
| Docketed: | September 21, 2016 |
| Lower Ct: | United States Court of Appeals for the Federal Circuit |
| Case Nos.: | (15-1456, 15-1460) |
| Decision Date: | March 18, 2016 |
| Rehearing Denied: | June 20, 2016 |
| ~~~Date~~~ | ~~~~~~~Proceedings and Orders~~~~~~~~~~~~~~~~~~~~~ |
| Sep 19 2016 |
Petition for a writ of certiorari filed. (Response due October 21, 2016) |
| Oct 4 2016 |
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents Acorda Therapeutics, Inc., and Pharma Ireland Limited. |
| Oct 6 2016 |
Order extending time to file response to petition to and including November 21, 2016, for all respondents. |
| Oct 21 2016 |
Brief amicus curiae of Generic Pharmaceutical Association filed. |
| Nov 21 2016 |
Brief of respondent AstraZeneca AB in opposition filed. |
| Nov 21 2016 |
Brief of respondents Acorda Therapeutics, Inc. and Alkermes Pharma Ireland Limited in opposition filed. |
| Dec 7 2016 |
DISTRIBUTED for Conference of January 6, 2017. |
| Dec 7 2016 |
Reply of petitioners Mylan Pharmaceuticals, et al. filed. (Distributed) |
| Dec 12 2016 |
Rescheduled. |
| Dec 21 2016 |
DISTRIBUTED for Conference of January 6, 2017. |
| Jan 9 2017 |
Petition DENIED. Justice Alito took no part in the consideration or decision of this petition. |
|